Research overview
A modified IGF-I analog developed for extended activity in laboratory systems.
Educational context is separated from the current-batch analytical documentation for the supplied material.
Long R3Modified IGF-I sequence incorporating an N-terminal extension and Arg3 substitution.
Receptor researchUsed to investigate IGF-receptor and insulin-receptor signaling systems.
Laboratory useCommonly discussed in cell-culture and analytical-detection literature.
Research nameLong R3 IGF-I
Compound classIGF-I analog
Presentation1MG
Material formLyophilized powder
Compound Profile & Technical Overview
Long R3 IGF-I is a modified insulin-like growth factor analog developed for laboratory applications. Published studies describe altered binding-protein interactions and activity in cell systems compared with native IGF-I. This 1MG presentation is currently unavailable. When stocked, identity, purity, measured content, and endotoxin documentation will be provided for the applicable lot.
Storage requirements
Protect from lightKeep refrigerated after reconstitutionAvoid freeze/thaw cycles
Lyophilized powder-20°CStated stability: 24+ months
Reconstituted solution2-8°CStated stability: approximately 30 days
Sealed lyophilized vials are described as heat-stable; refrigeration or freezing of sealed vials is optional. The 2-8°C guidance applies after reconstitution. Always follow the lot-specific documentation when it differs.
Published Research & References
Important research notice
This material is offered strictly for laboratory research use. It is not intended for human or veterinary use, food use, compounding, diagnosis, treatment, cure, or prevention of disease. Published findings are contextual and do not establish equivalence to this independently supplied material.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, FOOD, COSMETIC, OR MEDICAL PRODUCT